Cargando…

A pilot study of stereotactic body radiation therapy (SBRT) after surgery for stage III non-small cell lung cancer

BACKGROUND: Standard therapy for stage III non-small cell lung cancer with chemotherapy and conventional radiation has suboptimal outcomes. We hypothesized that a combination of surgery followed by stereotactic body radiation therapy (SBRT) would be a safe alternative. METHODS: Patients with stage I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Anurag K., Hennon, Mark, Ma, Sung Jun, Demmy, Todd L., Picone, Anthony, Dexter, Elizabeth U., Nwogu, Chumy, Attwood, Kristopher, Tan, Wei, Hermann, Gregory M., Fung-Kee-Fung, Simon, Malhotra, Harish K., Yendamuri, Sai, Gomez-Suescun, Jorge A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267846/ https://www.ncbi.nlm.nih.gov/pubmed/30497431 http://dx.doi.org/10.1186/s12885-018-5039-5

Ejemplares similares

Exceeding Radiation Dose to Volume Parameters for the Proximal Airways with Stereotactic Body Radiation Therapy Is More Likely for Ultracentral Lung Tumors and Associated with Worse Outcome
por: Farrugia, Mark, et al.
Publicado: (2021)

Analyzing the impact of minimally invasive surgical approaches on post-operative outcomes of pneumonectomy and sleeve lobectomy patients
por: Nitsche, Lindsay J., et al.
Publicado: (2023)

Advances in lung cancer surgery
por: Hennon, Mark W., et al.
Publicado: (2012)

Quality of Life After Stereotactic Body Radiation Therapy or Surgery for Early-Stage NSCLC: A Systematic Review
por: Iovoli, Austin J., et al.
Publicado: (2022)

Right Atrial Dose Is Associated with Worse Outcome in Patients Undergoing Definitive Stereotactic Body Radiation Therapy for Central Lung Tumors
por: Farrugia, Mark, et al.
Publicado: (2022)

Stereotactic Body Radiotherapy for the Treatment of Renal Tumors()
por: Hanzly, Michael, et al.
Publicado: (2014)

Dosimetric Implications of Number of Breathing Phases Used in the Definition of Internal Target Volume [ITV] in the Treatment of Non-Small Cell Lung Cancers Using Stereotactic Body Radiation Therapy (SBRT)
por: Heard, Von Darius, et al.
Publicado: (2019)

Systematic Review of Single-Fraction Stereotactic Body Radiation Therapy for Early Stage Non-Small-Cell Lung Cancer and Lung Oligometastases: How to Stop Worrying and Love One and Done
por: Bartl, Austin J., et al.
Publicado: (2022)

Association of neutrophil–lymphocyte ratio with survival in peripheral early-stage non-small cell lung cancer after stereotactic body radiation therapy
por: Huang, Karen, et al.
Publicado: (2023)

Hope for progress after 40 years of futility? Novel approaches in the treatment of advanced stage III and IV non-small-cell-lung cancer: Stereotactic body radiation therapy, mediastinal lymphadenectomy, and novel systemic therapy
por: Fung, Simon Fung Fee, et al.
Publicado: (2012)

肺癌外科手术进展
por: Hennon, Mark W., et al.
Publicado: (2013)

Stereotactic Body Radiotherapy (SBRT) for Intrahepatic and Hilar Cholangiocarcinoma
por: Mahadevan, Anand, et al.
Publicado: (2015)

Editorial: Novel Applications of Stereotactic Body Radiotherapy (SBRT)
por: Kotecha, Rupesh, et al.
Publicado: (2021)

Stereotactic body radiation therapy for non-small cell lung cancer: A review
por: Prezzano, Kavitha M, et al.
Publicado: (2019)

Stereotactic Body Radiation Therapy (SBRT) for Unresectable Pancreatic Carcinoma
por: Stauder, Michael C., et al.
Publicado: (2010)

Stereotactic Body Radiotherapy (SBRT) Reirradiation for Recurrent Pancreas Cancer
por: Dagoglu, Nergiz, et al.
Publicado: (2016)

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview
por: Zeng, Kang Liang, et al.
Publicado: (2019)

Stereotactic Body Radiotherapy (SBRT) for an Extracranial Arteriovenous Malformation of the Pelvis
por: Jooya, Alborz, et al.
Publicado: (2021)

Survival Benefit of Perioperative Systemic Chemotherapy for Patients With N0 to N1 NSCLC Having Synchronous Brain Metastasis
por: Vedire, Yeshwanth R., et al.
Publicado: (2023)

Stereotactic Body Radiation Therapy (SBRT) Combined With Chemotherapy for Unresected Pancreatic Adenocarcinoma
por: Gurka, Marie K., et al.
Publicado: (2017)

Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
por: Lischalk, Jonathan W., et al.
Publicado: (2016)

Editorial: Clinical Application of Stereotactic Body Radiotherapy (SBRT): Cranium to Prostate
por: Vargo, John A., et al.
Publicado: (2015)

Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma
por: Gkika, Eleni, et al.
Publicado: (2017)

Stereotactic body radiotherapy (SBRT) for locally advanced extrahepatic and intrahepatic cholangiocarcinoma
por: Sandler, Kiri A., et al.
Publicado: (2016)

Identifying predictors of on-table adaptation for pancreas stereotactic body radiotherapy (SBRT)
por: Wu, Trudy C., et al.
Publicado: (2023)

Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
por: Gurka, Marie K, et al.
Publicado: (2015)

Repeat stereotactic body radiotherapy (SBRT) for local recurrence of non-small cell lung cancer and lung metastasis after first SBRT
por: Ogawa, Yasutaka, et al.
Publicado: (2018)

Simultaneous Multiple Liver Metastasis Treated with Pencil Beam Proton Stereotactic Body Radiotherapy (SBRT)
por: Taunk, Neil K., et al.
Publicado: (2021)

Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma
por: Barney, Brandon M, et al.
Publicado: (2012)

Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments
por: Navarria, Pierina, et al.
Publicado: (2014)

Feasibility of Adaptive MR-guided Stereotactic Body Radiotherapy (SBRT) of Lung Tumors
por: Padgett, Kyle R, et al.
Publicado: (2018)

Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases
por: Yeung, Rosanna, et al.
Publicado: (2017)

Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)
por: Habl, Gregor, et al.
Publicado: (2017)

Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients
por: König, Laila, et al.
Publicado: (2020)

Stereotactic body radiotherapy (SBRT) for central and ultracentral node-negative lung tumors
por: Owen, Dawn, et al.
Publicado: (2020)

The Current Role of Stereotactic Body Radiation Therapy (SBRT) in Hepatocellular Carcinoma (HCC)
por: Kimura, Tomoki, et al.
Publicado: (2022)

Treatment of oligometastatic lung cancer with brain metastases using stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT)
por: Nikitas, John, et al.
Publicado: (2019)

Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT)
por: Reyngold, Marsha, et al.
Publicado: (2013)

Outcomes of Stereotactic Body Radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodules
por: Owen, Dawn, et al.
Publicado: (2015)

Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease
por: Gerum, Sabine, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_s39mbb0da8180tb3dlumnc4qid